isoxazoles has been researched along with ver-49009 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aherne, W; Barril, X; Box, G; Boxall, K; Brough, PA; Cansfield, JE; Cheung, KM; Drysdale, M; Dymock, B; Eccles, S; Foloppe, N; Hardcastle, A; Hayes, A; Holmes, JL; Hubbard, RE; James, K; Jones, K; Kalusa, A; Matthews, TP; McDonald, E; Pearl, L; Powers, MV; Prodromou, C; Raynaud, F; Sharp, SY; Surgenor, A; Workman, P; Wright, L | 1 |
1 other study(ies) available for isoxazoles and ver-49009
Article | Year |
---|---|
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues.
Topics: Adenosine Triphosphatases; Animals; Apoptosis; Biomarkers; Cell Cycle; Cell Proliferation; Crystallography, X-Ray; Drug Resistance, Neoplasm; Endothelial Cells; Female; HCT116 Cells; HSP90 Heat-Shock Proteins; HT29 Cells; Humans; Isoxazoles; Mice; Mice, Nude; NAD(P)H Dehydrogenase (Quinone); Protein Binding; Pyrazoles; Treatment Outcome; Xenograft Model Antitumor Assays | 2007 |